Kilitch Drugs (India) Limited has informed the Exchange regarding 'Corrigendum to Outcome of Board Meeting held on July 12, 2025'.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs has issued a corrigendum to its earlier board meeting outcome from July 12, 2025, correcting typographical errors in the timeline of its ongoing Rights Issue. The Last Date of Market Renunciation has been corrected to Monday, August 18, 2025; the Rights Issue Closing Date to Thursday, August 21, 2025; and the deadline for renunciation through off-market transfer and credit of Rights Entitlements to demat accounts to on or prior to Wednesday, August 20, 2025. The company has confirmed there are no other changes to the details previously submitted. The Managing Director, Mukund Mehta, has signed the corrigendum.
This is purely a date correction notice and does not change the substance of the rights issue. Shareholders and investors who were tracking the earlier (incorrect) September dates should now note the revised August 2025 deadlines for renunciation and closure of the rights issue.